ME2080 (stiripentol)

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
140	ドラベ症候群	1

140. ドラベ症候群

臨床試験数 : 116 / 薬物数 : 65 - (DrugBank : 17) / 標的遺伝子数 : 50 - 標的パスウェイ数 : 64

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-JapicCTI-101116	01/4/2010	28/04/2010	Open Phase III Study of ME2080 in Patients with Dravet Syndrome	Open Phase III Study of ME2080 in Patients with Dravet Syndrome	Dravet Syndrome	Intervention name : ME2080 (stiripentol) Dosage And administration of the intervention : 50mg/kg/day ...	Meiji Seika Pharma Co., Ltd. (formerly MEIJI SEIKA KAISHA Co., LTD.)	NULL		1	30	BOTH	25	Phase 3	NULL

First Previous1Next Last